REKINDLE THERAPEUTICS
REKINDLE THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(617) 669-0509
Total Funding:
1.1 M USD
Similar Organizations
AcureX Therapeutics
AcureX Therapeutics is a biotechnology company.
Capienda Biotech
Drug Discovery and Biotechnology
Courier Therapeutics
Courier Therapeutics is a biotechnology.
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
GeneWorx Capital
GeneWorx Capital is a technology venture development firm.
Lumosa Therapeutics
Lumosa Therapeutics, a public traded company i
Neuroene Therapeutics
Neuroene Therapeutics is a startup biotechnology company.
Pointcare Genomics
Pointcare Genomics Corporation is a biotech company.
Primmune Therapeutics
Primmune Therapeutics is a Biotechnology company.
RNADerm Therapeutics
RNADerm Therapeutics is a biotechnology company.
Savefruit
Savefruit is a biotechnology company.
Telum Therapeutics
Telum Therapeutics is a biotechnology company.
Tennessee Extracts
Tennessee Extracts is a biotechnology company.
TheraPten Biosciences
TheraPten Biosciences is a Canadian preclinical biotechnology company.
Venn Therapeutics
Venn Therapeutics is a privately held immuno-oncology company.
VivaZome Therapeutics
VivaZome Therapeutics is Australian biotech company,
XRad Therapeutics
XRad Therapeutics is a Biotechnology company.
Current Employees Featured
More informations about "Rekindle Therapeutics"
Rekindle Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 17, 2018: Venture Round - …See details»
Rekindle Therapeutics - Contacts, Employees, Board Members, …
Organization. Rekindle Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Rekindle …See details»
FORM D - SEC.gov
Nov 1, 2018 Rekindle Therapeutics Inc. Street Address 1 Street Address 2; 450 KENDALL STREET: 5TH FLOOR: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; …See details»
REKINDLE THERAPEUTICS INC. :: Massachusetts (US)
Mar 2, 2021 Free and open company data on Massachusetts (US) company REKINDLE THERAPEUTICS INC. (company number 001491647), 450 KENDALL STREET, …See details»
Rekindle Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 450 Kendall Street 5th Floor. Cambridge, Massachusetts, 02142, United States (617)669-0509See details»
ReCode Therapeutics - Powering the future …
Our pipeline of rare disease therapeutics uses optimized mRNA and gene correction with redosing capability. ... is a Managing Director at MPM Capital and serves as Chairman of MPM …See details»
Rekindle Therapeutics Inc. - fund raising filing - Form Ds
Nov 2, 2018 Rekindle Therapeutics Inc. Industry: Biotechnology (See others in industry) Address: 450 Kendall Street 5 Th Floor Cambridge, MA, 02142 Phone: 6176690509 . Filings. …See details»
Rekindle Therapeutics Stock Price, Funding, Valuation, Revenue ...
Nov 2, 2018 Rekindle Therapeutics has raised $1.1M over 1 rounds. Rekindle Therapeutics's latest funding round was a Private Equity for $1.1M on November 2, 2018. Date. Round. …See details»
REKINDLE THERAPEUTICS INC. in Cambridge, MA - Bizapedia
Feb 23, 2025 REKINDLE THERAPEUTICS INC. is a Massachusetts Foreign Profit Corporation filed on March 2, 2021. The company's File Number is listed as 001491647. The Registered …See details»
830901060 EIN ( TAX ID ) | REKINDLE THERAPEUTICS INC.
REKINDLE THERAPEUTICS INC. Conformed submission company name, business name, organization name, etc. 0001757971. Company's CIK. Company's Central Index Key (CIK). …See details»
O-GlcNAcylation in tumorigenesis and its implications for cancer ...
O-GlcNAcylation occurs on key proteins involved in chromatin organization, transcription mechanisms, and epigenetic regulation, thus reprogramming an oncogenic transcription …See details»
Rekindle Therapeutics - Crunchbase
Organization. Rekindle Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. …See details»
Targeting the acetylation signaling pathway in cancer therapy
A .gov website belongs to an official government organization in the United States . Secure .gov websites use HTTPS ... W.W. is a co-founder and consultant for the ReKindle Therapeutics. …See details»
Lactate fuels mitosis - PMC
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock Locked padlock icon ... W.W. is a co-founder and consultant for …See details»
Extracellular and nuclear PD-L1 in modulating cancer …
Sep 1, 2021 W.W. is a cofounder and consultant for the ReKindle Therapeutics. Other authors declare no competing financial interests. Recommended articles. References (52) J. Zhang …See details»
Rekindle Therapeutics - Updates, News, Events, Signals & Triggers
Rekindle Therapeutics is a biotechnology company. Recent News & Activity. Edit Recent News & Activity SectionSee details»
Targeting the acetylation signaling pathway in cancer therapy
Oct 1, 2022 W.W. is a co-founder and consultant for the ReKindle Therapeutics. Other authors declare no competing financial interests. Acknowledgements. ... Lysine acetylation Goes …See details»
Mitochondrial PD-L1 modulates cancer immunotherapy | Cell …
Jan 24, 2023 W.W. is a co-founder and consultant for the ReKindle Therapeutics. Rights and permissions. Reprints and permissions. About this article. Cite this article.See details»
Light-Controllable PROTACs for Temporospatial Control of Protein ...
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock Locked padlock icon ... WW is a co-founder and consultant for the …See details»
Eterna Therapeutics Changes Name to Ernexa Therapeutics to
1 day ago --Eterna Therapeutics, a leader in cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the company’ s new name: Ernexa Therapeutics …See details»